BIT
AZN icon

BlackRock Institutional Trust’s AstraZeneca AZN Stock Holding History

BlackRock Institutional Trust’s Portfolio AZN Stock Details AZN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q4 		– Sell
-127,020
Closed -$8.35M – 3833
2016
Q3 		$8.35M Buy
+127,020
New +$8.3M ﹤0.01% 2444
2016
Q2 		– Sell
-5,615
Closed -$316K – 3887
2016
Q1 		$316K Buy
5,615
+3,040
+118% +$183K ﹤0.01% 3545
2015
Q4 		$175K Sell
2,575
-10,373
-80% -$680K ﹤0.01% 3672
2015
Q3 		$824K Sell
12,948
-305
-2% -$20.1K ﹤0.01% 3392
2015
Q2 		$844K Sell
13,253
-28,680
-68% -$1.96M ﹤0.01% 3400
2015
Q1 		$2.87M Buy
41,933
+27,941
+200% +$1.94M ﹤0.01% 2955
2014
Q4 		$985K Buy
13,992
+2,502
+22% +$179K ﹤0.01% 3359
2014
Q3 		$821K Buy
11,490
+1,657
+17% +$121K ﹤0.01% 3378
2014
Q2 		$731K Sell
9,833
-100,567
-91% -$7.27M ﹤0.01% 3501
2014
Q1 		$7.16M Buy
110,400
+7,300
+7% +$471K ﹤0.01% 2613
2013
Q4 		$6.12M Buy
103,100
+22,500
+28% +$1.22M ﹤0.01% 2690
2013
Q3 		$4.19M Buy
80,600
+17,000
+27% +$854K ﹤0.01% 2811
2013
Q2 		$3.01M Buy
+63,600
New +$3.24M ﹤0.01% 2909

Other funds holding AZN

Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
Dodge & Cox
Dodge & Cox San Francisco, California $191B AUM 17.5% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
EIP
Epoch Investment Partners New York $17.6B AUM 34.17% 1-Year Est. Return
BIM
BlackRock Investment Management Wilmington, Delaware $86.4B AUM 16.83% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
PI
Putnam Investments Boston, Massachusetts $75.7B AUM 34.45% 1-Year Est. Return

BlackRock Institutional Trust's AZN Position: Q4 2016 in Review

BlackRock Institutional Trust sold out of AstraZeneca (AZN) in Q4 2016, closing a stake of 127,020 shares — an estimated $8.35M sold.

BlackRock Institutional Trust first reported a position in AZN in Q2 2013 and held it in 13 quarters. The position peaked at $8.35M in Q3 2016. 450 funds tracked by Wall St. Rank hold AZN as of Q4 2016.

  • BlackRock Institutional Trust reported no remaining AstraZeneca position as of Q4 2016 after selling out during the quarter.
  • BlackRock Institutional Trust sold 127,020 AstraZeneca shares in Q4 2016, an estimated $8.35M.
  • BlackRock Institutional Trust first reported a position in AstraZeneca in Q2 2013 and held it in 13 quarters.
  • BlackRock Institutional Trust's AstraZeneca position peaked at $8.35M in Q3 2016.
  • 450 funds tracked by Wall St. Rank held AstraZeneca as of Q4 2016.

Based on BlackRock Institutional Trust's 13F filing for Q4 2016, filed 10 Feb 2017.